Differentiation of deep venous thrombosis from femoral vein mixing artifact on routine abdominopelvic CT

2015 ◽  
Vol 40 (8) ◽  
pp. 3191-3195 ◽  
Author(s):  
Ankur M. Doshi ◽  
David Hoffman ◽  
Andrea S. Kierans ◽  
Justin M. Ream ◽  
Andrew B. Rosenkrantz
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Femoral Vein ◽  
Abdominopelvic Ct

Proximal deep venous thrombosis following PTA of the superficial femoral artery – an obligation to disclose a complication that is rarely taken into account

VASA ◽  
2006 ◽  
Vol 35 (1) ◽  
pp. 41-44 ◽  
Author(s):  
Klein-Weigel ◽  
Pillokat ◽  
Klemens ◽  
Köning ◽  
Wolbergs ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Femoral Artery ◽  
Superficial Femoral Artery ◽  
Rare Complication ◽  
Femoral Vein ◽  
Vein Thrombosis ◽  
Explicit Information ◽  
Life Threatening ◽  
Legal Consequences

We report two cases of femoral vein thrombosis after arterial PTA and subsequent pressure stasis. We discuss the legal consequences of these complications for information policies. Because venous thrombembolism following an arterial PTA might cause serious sequel or life threatening complications, there is a clear obligation for explicit information of the patients about this rare complication.

Deep Venous Thrombosis and Pulmonary Embolism Caused by an Intravascular Synovial Sarcoma of the Common Femoral Vein

2012 ◽  
Vol 46 (8) ◽  
pp. 693-695 ◽  
Author(s):  
J. M. Schoneveld ◽  
E. Debing ◽  
G. Verfaillie ◽  
C. Geers ◽  
P. Van den Brande
Keyword(s):  
Pulmonary Embolism ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Synovial Sarcoma ◽  
Femoral Vein ◽  
Common Femoral Vein ◽  
The Common

In Patients With a Femoral Vein Deep Venous Thrombosis, Central Venous Imaging May Identify Potentially Treatable Iliocaval Thrombosis

2017 ◽  
Vol 5 (1) ◽  
pp. 153-154 ◽  
Author(s):  
Michael Barfield ◽  
Lowell Kabnick ◽  
Thomas Maldonado ◽  
Glenn Jacobowitz ◽  
Caron Rockman ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Femoral Vein ◽  
Central Venous

scholarly journals Images in Vascular Medicine: Intravascular fasciitis of the common femoral vein mimicking deep venous thrombosis

2020 ◽  
Vol 25 (6) ◽  
pp. 602-603
Author(s):  
Nan Li ◽  
Deng-Ke Hong ◽  
Xue-Xun Zheng ◽  
Ya-Dong Zhou ◽  
Xing-Sheng Chen
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Femoral Vein ◽  
Vascular Medicine ◽  
Common Femoral Vein ◽  
The Common ◽  
Intravascular Fasciitis

The development of persistent thrombotic masses in patients with deep venous thrombosis randomized to long-term anticoagulation treatment

VASA ◽  
2009 ◽  
Vol 38 (3) ◽  
pp. 238-244 ◽  
Author(s):  
Vítovec ◽  
Goláň ◽  
Roztočil ◽  
Linhart
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Standard Therapy ◽  
Femoral Vein ◽  
Duplex Ultrasound ◽  
Complete Regression ◽  
Cross Sectional ◽  
Anticoagulation Treatment ◽  
Significant Difference

Background: The aim of the study was to assess the regression rate of persistent echogenic masses in patients with idiopathic deep venous thrombosis (DVT) who were after initial 6 months randomized to long-term anticoagulation treatment or to discontinuation of anticoagulation. Patients and methods: We followed 168 patients with idiopathic DVT for two years since diagnosis. After 6 months of standard therapy (heparin / LMWH, warfarin with target INR 2-3) we randomized patients with persistent echogenic masses of over 20% of venous diameter to either discontinuation of warfarin or to continuation of warfarin for another 6 months. We evaluated the size of thrombotic masses with duplex ultrasound. Results: After 6 months of standard therapy complete regression was observed in 69 patients while in 99 patients echogenic masses persisted, with 71 patients maintaining an obstruction of at least 20% of venous cross-sectional area. 52 patients were randomized. 27 patients continued warfarin therapy and in 25 patients warfarin was discontinued. After discontinuation of warfarin a further trend to regression was seen in both groups. A significant difference in regression of thrombotic masses between the 6th and 12th month of follow up was seen in patients continuing to receive warfarin, both within the popliteal vein (2.81 ± 1.56 vs. 2.10 ± 1.67 mm, p < 0.05) and the femoral vein (3.95 ± 2.74 vs. 2.30 ± 1.34 mm, p < 0.05). Conclusions: After 6 months of DVT treatment persistent echogenic masses can be found in almost two thirds of patients. Even after discontinuation of anticoagulation treatment echogenic masses further regress. However, the rate of regression in patients with deep venous thrombosis between the 6th and 12th month was greater in patients randomized to continue warfarin during this period than in patients without anticoagulation.

Adventitial Cystic Disease of the Common Femoral Vein—A Rare Mimic of Deep Venous Thrombosis: A Case Report

2016 ◽  
Vol 165 (1) ◽  
pp. 75 ◽  
Author(s):  
Sean O'Loghlen ◽  
Grayson J. Hall ◽  
Nadil Zeiadin ◽  
Laura Milne ◽  
Benedetto Mussari
Keyword(s):  
Case Report ◽  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Femoral Vein ◽  
Cystic Disease ◽  
Common Femoral Vein ◽  
Adventitial Cystic Disease ◽  
The Common

FEMORAL VEIN CATHETER RELATED DEEP VENOUS THROMBOSIS

1991 ◽  
Vol 31 (7) ◽  
pp. 1034 ◽  
Author(s):  
J. W. Meredith ◽  
E. A. OʼNeil ◽  
D. C. Snow ◽  
K J Hansen
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Femoral Vein ◽  
Vein Catheter
Sign in / Sign up

Export Citation Format

Share Document